(Q34069802)

30 July 2017

1 reference

title

Pneumococcal conjugate vaccines - implications for community antibiotic prescribing (English)

1 reference

30 July 2017

Tan TQ

1

1 reference

30 July 2017

publication date

1 October 2000

1 reference

Current Opinion in Microbiology

30 July 2017

published in

1 reference

30 July 2017

volume

3

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

502-507

1 reference

The burden of pneumococcal disease: the role of conjugate vaccines

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

The epidemiology of pneumococcal infection in children in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Three-year multicenter surveillance of systemic pneumococcal infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Drug-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Etiology and treatment of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG).

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Acute community-acquired sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Complicated parapneumonic effusions in children caused by penicillin-nonsusceptible Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Pneumococcal meningitis in children: prognostic indicators and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Bacterial meningitis in the United States in 1995. Active Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Streptococcus pneumoniae: impact of antibiotic resistance in pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Pneumococcal vaccine: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Pneumococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Immunogenicity of pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Carriage of pneumococci after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900130-2

7 January 2021

10.1016/S1369-5274(00)00130-2

Identifiers

DOI

1 reference

30 July 2017

1 reference